Stockwinners Market Radar for June 15, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:12 EDT Cathie Wood's ARK Investment bought 47.6K shares of Verve Therapeutics today

19:13 EDT Remitly Global COO sells 31,667 common shares - In a regulatory filing, Remitly Global COO Joshua Hug disclosed the sale of 31,667 common shares of the company on June 13 at a price of $20.0007 per share.

18:21 EDT GDIT awarded $383M U.S. Navy contract - General Dynamics Information Technology, a business unit of General Dynamics, announced that it was awarded a $383M training support services contract by the Naval Surface Warfare Center Dahlgren Division in Virginia. The contract, awarded on behalf of Surface Combat Systems Training Command, has a one-year base period and four option years. SCSTC provides the Navy and its allies with highly trained warfighters to maintain, operate, and tactically employ surface combat systems across the spectrum of operations. Over the life of the contract, GDIT will train more than 100,000 U.S. and allied sailors in classroom and simulation settings ashore and aboard Navy warships around the globe. Specifically, the company will provide instructor support, curriculum development, training aids and program management services. "For over 30 years, we have supported a wide range of Navy training activities," said Brian Sheridan, GDIT's senior vice president for Defense. "We are looking forward to continuing to provide the Navy with modern training services to strengthen its overall fleet operations and warfighting readiness."

18:00 EDT New Mexico Water receives NMPRC approval to acquire Monterey Water - The New Mexico Public Regulation Commission has given approval for New Mexico Water Service, a subsidiary of California Water Service Group, to acquire the assets of Monterey Water Company, paving the way for New Mexico Water to close the purchase and provide regulated water utility service to Monterey's customers. The acquisition remains subject to customary closing conditions and is expected to close this summer. Upon closing, New Mexico Water-a subsidiary of California Water Service Group (Group)-will own and operate the water system, which is less than a half-mile from New Mexico Water's Rio Del Oro system. The Monterey system, which will become part of the Rio Del Oro service area, currently serves 380 residential customers; about 100 undeveloped lots could also be served in the future if and when they are developed.

17:36 EDT Adobe says FY23 targets predict solid operating margin expansion in second half - Says proud of PDF. Says best of PDF is yet to come. Says Figma acquisition will expand total addressable market. Says transaction should close by end of 2023. Says digital media business is on a roll. Says excited about Firefly. Comments taken from Q2 earnings conference call.

17:24 EDT Goodyear Tire selected Airbus to provide tires for A321XLR - The company states: The Goodyear Flight Radial is one of Goodyear's most advanced aviation products with technologies and features supporting dimensional stability for longer life and increased cut resistance. The tire's radial construction promotes more landings and optimized bead design offers reduced weight. Goodyear will feature the Airbus fitment selection for the new A321XLR as part of the brand presence at the Paris Air Show from June 19-25, 2023. The ultra-lightweight tire has received system part certification from Airbus, a leading aircraft manufacturer, and leads the way in optimizing efficiency and weight reduction."

17:06 EDT Latch regains compliance with Nasdaq minimum bid price requirement - Latch, Inc. announced that on June 15, 2023, the company received a written notice from the Listing Qualifications Department of the Nasdaq Stock Market that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1) for continued listing on Nasdaq. In order to regain compliance with the Minimum Bid Price Requirement, the company's common stock was required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive trading days. The Minimum Bid Price Requirement was met on June 14, 2023. Accordingly, in the Notice, Nasdaq stated that the matter is now closed. There can be no assurance, however, that the company will be able to maintain compliance with the Minimum Bid Price Requirement in the future.

17:03 EDT Hudbay Minerals' acquisition of Copper Mountain approved by BC Court - Hudbay Minerals and Copper Mountain announced that the Supreme Court of British Columbia has issued a final order approving the previously announced plan of arrangement under the Business Corporations Act pursuant to which Hudbay will acquire all of the issued and outstanding common shares of Copper Mountain. The transaction remains subject to the satisfaction of certain other customary closing conditions for transactions of this nature. The Toronto Stock Exchange has conditionally approved the listing of the Hudbay common shares to be issued in connection with the Transaction, and the requisite regulatory approval for the Transaction under the Competition Act Canada has been obtained. It is currently anticipated that the effective date of the Transaction will occur on or about June 20.

17:00 EDT CNA names Dan Franzetti chief administrative officer - CNA announced the appointment of Dan Franzetti to a newly created position of Chief Administrative Officer, reporting to Dino Robusto. In this role, Franzetti will have oversight for a broad set of enterprise strategic functions including the global claims and legal organizations, compliance, government relations and a number of corporate services functions. "The addition of a Chief Administrative Officer is an important next step in the evolution of CNA's executive leadership team, and I am confident that Dan will bring the same level of impactful leadership as he did in his role as Global Head of Claims at CNA." Robusto said. "Dan's breadth of expertise built across a career spanning three decades in the P&C industry, positions him perfectly for the CAO role and he will contribute meaningfully to the continued success of CNA."

16:55 EDT Beachbody Company names Mark Goldston as Executive Chairman - The Beachbody Company announces the appointment of Mark R. Goldston to the newly formed role of Executive Chairman of BODi's Board of Directors, effective June 15, 2023. In this strategic role, Mr. Goldston will be instrumental in partnering with the company's co-founder and CEO Carl Daikeler in guiding the Company's transformation, driving profitability, and leveraging its remarkable assets to unlock opportunities for growth.

16:43 EDT FCM: MindMed's plan to hold AGM regardless of participation 'appalling' - "FCM Holding condemns Mind Medicine for its apparent plan to manipulate its corporate machinery to follow through with its 2023 annual general meeting and election of directors without earning the substantive support of its shareholders. At today's AGM, MindMed failed to satisfy the basic legal requirement for shareholders to take action at the meeting - the presence of 1/3 of its shares at the AGM. FCM contends this extraordinarily low level of shareholder participation reflects deep shareholder dissatisfaction and MindMed's persistent refusal to meaningfully engage with shareholders. Despite not achieving quorum at the AGM, MindMed has announced its intention to hold an adjourned meeting on June 21 regardless of the level of shareholder participation. This flies in the face of MindMed's own public disclosures in its regulatory filings that 12,863,281 shares must be voted at the AGM for it to be valid. Now, MindMed says that whoever shows up at its adjourned AGM - even a single share - will be enough! "MindMed's inability to meet quorum is illustrative of the Company's failure to engage shareholders and a symptom that the shareholder base is frustrated with current management. It is unfortunate, but not surprising, that the board would take inappropriate actions which imperil MindMed's future to protect the entrenched board," says Mr. Vivek Jain, FCM nominee.," said Mind Medicine investor FCM.

16:35 EDT Heritage Commerce chief credit officer Margo Butsch to retire - Heritage Commerce announced that Margo Butsch will be retiring from her position as executive VP and chief credit officer, after eight years with the bank.

16:33 EDT Enovix achieves Q2 forecast of 18K cell units - The company states: "Enovix, an advanced silicon battery company, announced it has already achieved its second quarter forecast of 18,000 units manufactured out of its Fab1 location in Fremont, and expects to exceed its quarterly guidance for the number of units produced, with more than two weeks remaining in the quarter. For full-year 2023, the company continues to expect to produce 180,000 cells for customers from Fab1 to support broad qualification activities and customer products. Enovix previously announced it will begin high-volume manufacturing at its Fab2 location in Penang, Malaysia, next year. When fully ramped, the Gen2 Autoline 1 in Fab2 will have the capacity to produce more than nine million batteries annually." Shares of Enovix are up 5% at $14.30 following the announcement.

16:31 EDT Virgin Galactic jumps 23% to $5.00 after announcing start of commercial service

16:24 EDT Coterra Energy CFO and Chief HR Officer to retire - Coterra Energy announced the retirement of two Executive Officers of the Company, effective September 30, 2023. Scott C. Schroeder, Executive Vice President and CFO, will be retiring after a nearly 28-year career at Cabot Oil & Gas Corporation and Coterra Energy Inc. Christopher H. Clason, Senior Vice President and Chief Human Resources Officer, will also be retiring after nearly five years with the organization and a career that has spanned over 25 years in executive leadership. Shane E. Young has been appointed to the role of Executive Vice President and Chief Financial Officer. Mr. Young has an extensive background in upstream energy having worked both in investment banking and as a CFO for nearly the last decade, most recently at Talos Energy. Andrea M. Alexander has been appointed to the role of Senior Vice President and Chief Human Resources Officer. Ms. Alexander is a proven Human Resources leader with a history of building effective organizations and leading high-performing teams. She brings a wealth of experience from extensive corporate and consulting leadership.

16:22 EDT NextEra Energy CEO buys $1.0M in common stock - In a regulatory filing, NextEra disclosed that its CEO John Ketchum bought 13.6K shares of common stock on June 14th in a total transaction size of $1.0M.

16:17 EDT Biodexa Pharmaceuticals plans appeal of NASDAQ delisting determination - Biodexa Pharmaceuticals announced that on June 14 it received a Staff determination letter from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company of the Staff's determination to delist the Company's securities from The Nasdaq Capital Market because the Company's securities have had a closing bid price below $0.10 for ten consecutive trading days, which triggers a notice of delisting pursuant to Nasdaq Listing Rule 5810 . In addition to the $0.10 Rule delisting notice, the Company also currently fails to satisfy the requirement that the closing bid price of its securities remain at $1.00 or higher as required by Nasdaq Listing Rule 5810 . The Company has received a period of 180 calendar days to return to compliance with the Minimum Bid Price Rule, which compliance period expires on July 31 If the Company's securities fail to regain compliance with the Minimum Bid Price Rule, Nasdaq will have an additional basis for delisting the securities. The Company plans to appeal the Staff's determination to a Hearings Panel .

16:16 EDT Disney CFO McCarthy to step down, Lansberry named interim CFO - The Walt Disney Company's Senior Executive Vice President and Chief Financial Officer Christine M. McCarthy will be stepping down from her role and taking a family medical leave of absence, and veteran Disney executive Kevin Lansberry, Executive Vice President and Chief Financial Officer of Disney Parks, Experiences and Products, will serve as the company's Interim CFO, effective July 1, it was announced by Bob Iger, Chief Executive Officer, The Walt Disney Company. McCarthy will continue as a strategic advisor to the company during her leave and will assist with the process of identifying and onboarding a long-term successor to ensure a smooth and successful transition. "Christine McCarthy is one of the most admired financial executives in America, and her impact on The Walt Disney Company during 23 years of dedicated service cannot be overstated," Iger said. "Christine has served as a key strategic anchor during a period of great transformation, and she and I have discussed her desire to ensure an orderly and successful CFO succession in advance of the company's transition to its next chief executive officer. She is stepping down from her CFO role as she takes family medical leave, but has graciously offered to move into an advisory position to assist her successor in assuming the duties she has so expertly handled these many years." Lansberry has agreed to serve as Interim CFO while a thorough search of internal and external candidates is conducted for a permanent replacement. "Kevin has been with the company for more than three decades and is a trusted lieutenant to Christine. Having expertly served as CFO at our largest business segment since 2017, he has my complete confidence, and I look forward to working with him during this transition," Iger said.

16:14 EDT Beyond Air licenses rights to nNOS inhibitors to treat Autism from HUJI - Beyond Air announced that it has entered into an agreement with Yissum Research Development Company of the Hebrew University of Jerusalem to license the commercial rights for multiple neuronal nitric oxide synthase nNOS inhibitor candidates, currently being developed for the treatment of autism spectrum disorder ASD and other neurological conditions. There are currently no therapies approved by the U.S. Food and Drug Administration specifically for the treatment of ASD. "We are the world's leading developer of nitric oxide based therapies, as evidenced by FDA approval of our LungFit PH to treat term and near-term neonates with hypoxic respiratory failure ("persistent pulmonary hypertension of the newborn" or "PPHN"), our robust pipeline of revolutionary LungFit systems in clinical trials for the treatment of various severe lung infections using inhaled NO, the development of ultra-high concentration NO to treat solid tumors through Beyond Cancer, and now the development of nNOS inhibitors to treat autism," stated Steve Lisi, Chairman and Chief Executive Officer of Beyond Air. "The results of groundbreaking preclinical studies conducted by Dr. Haitham Amal of the Hebrew University suggest a direct link between NO and ASD, which may lead to the first therapy to reverse ASD behavioral deficits. We are pleased to have entered into this partnership and look forward to initiating a planned first-in-human study in 2025."

16:11 EDT Agile Therapeutics reports Twirla to become available through FPA Women's Health - Agile Therapeutics announced that Twirla will become available through FPA Women's Health. The company expects this increased availability to positively impact growth of demand and factory sales in the non-retail channel, which grew 20% and 15% respectively from the fourth quarter 2022 to first quarter 2023. As California's leading provider of in-clinic and telehealth women's healthcare, FPA Women's Health has 24 locations throughout Los Angeles County and other regions across California.

16:08 EDT Adobe gains about 2% to $499 after Q2 earnings beat and guidance raise

16:07 EDT Mustang Bio announces final data from follicular lymphoma cohort of MB-106 trial - Mustang Bio announced that final data from the follicular lymphoma cohort of the single-institution Phase 1/2 clinical trial of MB-106 demonstrate treatment with the CD20-targeted, autologous CAR T-cell therapy resulted in high overall response, or ORR, and complete response, or CR, rates and CAR T persistence in FL patients. MB-106 is being developed in a collaboration between Mustang and Fred Hutchinson Cancer Center to treat patients with relapsed or refractory B-cell non-Hodgkin lymphomas and chronic lymphocytic leukemia. The final FL cohort results from the Phase 1/2 clinical trial being conducted at Fred Hutch were presented by Mazyar Shadman, Associate Professor and physician at Fred Hutch and University of Washington, at the 17th International Conference on Malignant Lymphoma. A total of 20 patients with relapsed FL with confirmed CD20 expression participated in the study and had day 28 assessment. Median age was 63 years, and median prior lines of treatment was 4. High-risk features included patients with progression of disease within 24 months of first-line chemoimmunotherapy, history of histologic transformation, prior treatment with a CD19 target CAR T. ORR was 95% and CR rate was 80%. Patients who received higher dose levels had an ORR of 100% and a CR rate of 91%. Ten patients are in remission over one year, seven of whom are over two years. One patient, previously treated with a CD19-targeted CAR T-cell therapy, achieved a CR and remains in remission after 18 months. From a safety profile perspective, all cytokine release syndrome events were grade 1 or grade 2, with no grade greater than or equal to 3 CRS events. There was no occurrence of immune effector cell-associated neurotoxicity syndrome of any grade.

16:06 EDT RBB Bancorp names Johnny Lee president, chief banking officer - RBB Bancorp announced the appointment of Johnny Lee as President and Chief Banking Officer of Royal Business Bank and RBB Bancorp. With an impressive 33 years of banking experience, Lee brings a wealth of knowledge in strategic planning, bank administration, branch management, commercial banking, and risk management. Prior to joining the company, Lee held the position of Senior Managing Director and Head of International and Commercial Banking at East West Bank, a publicly traded bank with $64 billion in assets. During his tenure of 10 years at East West Bank, he served in various senior roles, contributing significantly to the bank's success. David Morris, RBB's Chief Executive Officer, expressed enthusiasm for Mr. Lee's appointment, stating, "We are thrilled to have Johnny join us as President and Chief Banking Officer and look forward to his contributions to the Company. As we strive to deliver value to our customers, community, and shareholders, we continue to attract top-tier banking professionals to our team and directors to our Board."

15:04 EDT New Quantum to become public in U.S. via deal with Canna-Global Acquisition - Canna-Global Acquisition Corp (CNGL), a special purpose acquisition company, announced the signing of a definitive Bid Implementation and Business Acquisition Agreement with Sydney-based New Quantum Holdings Pty Ltd., a provider of a vertically integrated technology and infrastructure offering for financial services firms, that will result in New Quantum becoming a wholly-owned subsidiary of Canna Global, which is expected to be listed on the Nasdaq Global Market under the ticker symbol "NQH" The business combination transaction reflects an estimated proforma enterprise value of New Quantum at $800M and follows New Quantum's recent acquisition of a majority interest in Morrison Securities from the ASX-listed, Sequoia Financial Group in June 2023. The combined entities have, in addition to a leading technology platform, A$20B of committed funds under management, and a qualified additional pipeline of A$80B. New Quantum CEO Jong Chung comments, "New Quantum's technology and platform have the potential to revolutionize the financial services industry by providing high value services at a scale only their technology makes possible. When we acquired 80% of Morrison Securities, it not only confirmed our leadership position in the Australian fintech industry, but also provided us with the ballast to rapidly expand our offering in the market."

14:35 EDT Rivian Automotive up 5% in afternoon trading amid conference presentation - Rivian shares are up 5%, o4 80c, to $15.52 as its CFO, Claire McDonough, participates in a fireside chat at the Deutsche Bank Global Auto Industry Conference that started at 2:20 pm ET.

14:32 EDT Reg A+ offering fits Thumzup vision of democratization, CEO says

14:32 EDT Thumzup looking to be 'Uber of social media marketing,' CEO says

14:26 EDT Argonaut Gold jumps 4% after first gold pour at Magino Mine - Argonaut Gold is up 4% or 2c per share to 46c per share in afternoon trading on Thursday after announcing that it achieved first gold pour at its Magino Mine on June 14th. Process plant ramp-up remains on schedule with commercial production expected in the third quarter of 2023. Magino is Argonaut's first Canadian operation and is located in Dubreuilville, Ontario. "With the first gold pour milestone behind us, we are now focused on completing commissioning and ramping up the mill to steady state. In addition, we are looking to further grow our flagship gold mine as we commence a reserve development drilling program intending to increase reserves in combination with studies to expand and optimize mill throughput, both scheduled to begin later this summer," stated Marc Leduc, Chief Operating Officer. Magino is expected to produce between 72,000 to 81,000 ounces of gold in 2023 at cash costs of between $850 and $950 per ounce and approximately 148,000 ounces of gold at a cash cost of $868 per ounce in 2024, its first full year of production. Reference Link

14:04 EDT Cano Health reports company's two director nominees re-elected - Cano Health announced the results of its annual stockholders' meeting, stating that based on the vote tabulation by the company's proxy solicitor, Cano Health's two director nominees, Dr. Alan Muney and Kim Rivera, have been re-elected to the company's board of directors. "We take seriously the input we have received from our stockholders and they can expect us to take further action to ensure we unlock the substantial value that is embedded in Cano Health's unique platform. With the election now concluded, our Board is focusing all our energy and attention on executing our plan to drive sustainable long-term growth and profitability by sharpening our focus on Medicare Advantage, unlocking embedded medical center profitability, streamlining operations, strengthening cash flows, and optimizing our management team and governance. We are poised to capitalize on the significant opportunities in front of us and will not be distracted by the former directors' continued misrepresentations of events and self-serving agenda. While we acknowledge there was a significant withhold vote, we believe that the two world-class directors who have been re-elected to our Board will continue to benefit the Company and our stockholders through their significant executive leadership experience and healthcare expertise, as the Board collectively works to realize Cano Health's enormous potential," said Solomon Trujillo, Chairman of the Board.

13:54 EDT Pedevco spikes 8% higher after announcing 'significantly expanded' leasehold - Shares of Texas-based oil and gas company Pedevco are up 8% or 7c per share to 91c in afternoon trading on Thursday after announcing earlier on Thursday, that it has significantly expanded its oil and gas leasehold into Southeastern Wyoming through the acquisition of over 4,000 net leasehold acres in the highly prospective Codell play in Southeastern Wyoming's D-J Basin, increasing the Company's D-J Basin footprint to over 17,000 net acres across Northeastern Colorado and Southeastern Wyoming. "With its attractive economics, the Company believes that the Codell play of the D-J Basin in Southeastern Wyoming offers one of the most exciting oil and gas expansion and development opportunities in the U.S., with nearby recent development exceeding 750 MBOE EURs per well," noted the company. J. Douglas Schick, President of the Company, stated, "We are very pleased to announce the expansion of our D-J Basin footprint into Southeastern Wyoming and continued growth and development of our D-J Basin position. In the present environment, we believe our capital is better spent and will yield greater returns growing our production and reserves organically versus seeking to acquire existing production. Throughout 2021 and 2022 our team researched multiple new highly prospective oil rich plays, ultimately identifying the emerging Codell play in Southeastern Wyoming as an ideal target due to the impressive well results of operators in the area, a favorable regulatory environment, and geological, geographical and operational similarities with our existing D-J Basin position. We look forward to commencing development of our new Wyoming position, with first development anticipated in 2024."

13:40 EDT XPeng rolls out ADAS for urban driving in Beijing, China - XPeng announced the official launch of City NGP, or Navigation Guided Pilot, in Beijing, making it China's first Advanced Driver Assistance System, or ADAS, available in the urban areas of Beijing, applicable on the major ring roads and expressways. With the beta version currently offered on select XPeng models in Beijing, City NGP can be accessed on XPeng G9 Max and P7i Max versions through OTA, or Over-the-Air, update of Xmart OS 4.3.0, as well as on XPeng P5 P version which upgraded to Xmart OS 3.5.0. In the second half of 2023, XPeng will gradually release its ADAS functions for Chinese cities or urban areas without HD map coverage. It also plans to offer customized NGP capabilities for daily commuting nationwide. These initiatives will cater to a wider range of driving scenarios and provide enhanced intelligent driving experiences for users in various environments.

13:20 EDT Corner Growth Acquisition Corp trading halted, volatility trading pause

12:16 EDT Priveterra Acquisition Corp trading resumes

12:03 EDT NexGen Energy signs impact benefit agreement with MN-S NR2, MN-S - NexGen Energy announced the signing of an Impact Benefit Agreement with the Metis Nation - Saskatchewan Northern Region 2 and the Mdtis Nation - Saskatchewan, covering all phases of the Rook I Project, which hosts the 100% owned Arrow uranium deposit. The signing of an IBA with the MN-S follows the signing of Benefit Agreements with each of the Clearwater River Dene Nation, Birch Narrows Dene Nation, and Buffalo River Dene Nation. These four Nations collectively represent the First Nation and Metis communities for which the Saskatchewan Ministry of Environment assigned procedural aspects of the Duty to Consult for the Project to NexGen, and which have been identified by NexGen as the primary Indigenous Nations for consultation in consideration of the federal requirements of the Canadian Nuclear Safety Commission

12:00 EDT Amprius Technologies falls -5.8% - Amprius Technologies is down -5.8%, or -55c to $8.88.

12:00 EDT Wiley falls -15.0% - Wiley is down -15.0%, or -$5.50 to $31.12.

12:00 EDT C3.ai rises 13.1% - C3.ai is up 13.1%, or $5.60 to $48.44.

11:51 EDT ArcLight acquires incremental interest in NGPL from Brookfield InfrastructureKinder Morgan - An affiliate of ArcLight Capital Partnes has acquired an incremental 12.5% interest in Natural Gas Pipeline Company of America from Brookfield Infrastructure Partners (BIP). As a result of this transaction, ArcLight's ownership in NGPL increased to 37.5% while Brookfield Infrastructure retains a 25% interest. Kinder Morgan, Inc. (KMI) continues to operate the pipeline and holds a 37.5% interest in NGPL.

11:46 EDT Lennar sees Q4 gross margin sequentially higher than Q3

11:38 EDT Live Nation to start 'all-in pricing experience' for concerts as of September - Live Nation will begin providing "a new all-in pricing experience" for concerts at the venues and festivals the company operates across the United States starting this September, the company announced. "Live Nation has been advocating for all-in pricing to become law for many years, and joined a forum at the White House today hosted by President Biden to discuss this and other reforms that would benefit artists and consumers. With all-in pricing, fans can see upfront the full ticket price, including fees. Fans typically know tickets will include service fees, but seeing the total cost from the start makes buying tickets easier and consistent with other retail shopping experiences," the company stated. Tom See, President of Venue Nation, added: "Live Nation is proud to provide fans with a better ticket buying experience. We have thousands of crew working behind the scenes every day to help artists share their music live with fans, and we'll continue advocating for innovations and reforms that protect that amazing connection."

11:16 EDT Lennar: Supply shortage won't resolve in near-term

11:14 EDT Lennar: Housing market has leveled, margins have bottomed/recovering - Sees market remaining "constructive" for homebuilders.

11:12 EDT Lennar: Strong demand for housing has returned

11:08 EDT Traverse Point Condominiums signs contract for Knightscope ASR service - Knightscope announced that Traverse Point Condominiums in Henderson, NV, signed a contract for its K5 Autonomous Security Robot subscription service.

10:57 EDT Splash Beverage expands distribution in the Eastern U.S. - Splash Beverage Group has broadened its growing distribution coverage. In Central Virginia, Splash has expanded its existing partnership with Brown Distributing, in which Brown will now add TapouT and Pulpoloco to its portfolio of beverages. In addition, Splash announced a partnership with Pine State Beverage, covering the majority of the state of Maine. The two companies have entered into distribution agreements for two of Splash's brands, Copa di Vino and Pulpoloco.

10:42 EDT Manchester United up 12% to $26.05 following halt for volatility

10:42 EDT Manchester United jumps 15% after Reuters says Qatar Sheikh exclusive bidder - The shares are halted for volatility after the Reuters report.

10:41 EDT Chart, Kathairos expand partnership for methane emission reduction technology - Chart Industries announced the furthering of its partnership and contract with Calgary-based cleantech startup, Kathairos Solutions, which already included Chart's MicroBulk tanks to now include products such as Orca Delivery Systems. The two companies have agreed to extend their contract for a minimum of two more years. Chart said, "This increase in the scope of our partnership was initiated due to the positive feedback from the market about their combined solution being effective and easy to operate and the resulting rapid adoption and scale rollout of industry leading companies."

10:37 EDT Manchester United trading halted, volatility trading pause

10:09 EDT Top KingWin Ltd trading resumes

10:00 EDT LiveOne enters exclusive joint strategic partnership with Legible - LiveOne announced that it has entered into an exclusive joint strategic partnership with Legible, a global book infotainment and media company, to provide streaming access to Legible's audiobook and eBook content for the automotive sector in North America. This partnership will provide a unique opportunity to be the first to provide seamless access to audiobooks and eBooks to book lovers while in their cars. Legible's technology will facilitate integration of audiobooks and eBook content directly into vehicle infotainment systems.

10:00 EDT Enerflex falls -6.1% - Enerflex is down -6.1%, or -40c to $6.08.

10:00 EDT Earthstone Energy rises 6.8% - Earthstone Energy is up 6.8%, or 87c to $13.65.

10:00 EDT Leju rises 35.6% - Leju is up 35.6%, or $1.04 to $3.96.

09:47 EDT ProShares UltraShort Bloomberg Natural Gas falls -5.8% - ProShares UltraShort Bloomberg Natural Gas is down -5.8%, or -$4.44 to $72.15.

09:47 EDT Wiley falls -7.1% - Wiley is down -7.1%, or -$2.61 to $34.01.

09:47 EDT Earthstone Energy rises 6.3% - Earthstone Energy is up 6.3%, or 81c to $13.59.

09:39 EDT Inspira Technologies presents lastest investor deck on acute respiratory care - Inspira presents its latest investor deck, unveiling opportunities that have the potential to reshape the acute respiratory care landscape introducing empowered breathing without the use of lungs. The company said, "INSPIRA AI is embedded into the INSPIRA ART500 to target hyper-personalized patient care, providing empowered breathing without lungs. We believe that our technologies have the potential to prevent the need for patients to be treated with mechanical ventilators that necessitate intubation and induced comas. We continuously strive to push the boundaries of innovation, leveraging advanced technologies to develop groundbreaking medical devices to increase and enhance the use of extracorporeal blood circulation, whereby the patient's blood is circulated outside of the body for oxygen enrichment and carbon dioxide removal and is then returned to the patient. Our Investor Deck highlights our vision, achievements, our focus going forward and what we believe are remarkable opportunities. In addition, our projected targets and milestones for the second half of 2023 include the submission of the INSPIRA ART100 to the U.S. Food and Drug Administration via the 510(k) pathway, additional strategic and distribution agreements for the INSPIRA ART500, the INSPIRA ART100 and the HYLA(TM) blood sensor. We also aim to benefit from additional patent grants for the INSPIRA ART500 as well as broadening our collaborative relationships and programs with key medical institutes."

09:34 EDT Allogene Therapeutics provides additional ALLO-501/501A Phase 1 data - Allogene Therapeutics at the International Conference on Malignant Lymphoma in Lugano, Switzerland presented updated data from the Phase 1 ALPHA/ALPHA2 trials of ALLO-501/501A in 33 CAR T naive patients with relapsed/refractory large B-cell lymphoma treated with the Alloy manufacturing process material across different CAR T dosing and lymphodepletion regimens. Earlier in June, data from the 12 patients, a subset of these 33 CAR T naive patients, who received regimen being utilized in ongoing Phase 2 trials was presented at American Society of Clinical Oncology Annual Meeting. The updated analysis of ALPHA/ALPHA2 examined data from all 33 CAR T-naive patients with r/r LBCL who were treated with a single infusion or consolidation therapy of ALLO-501/501A manufactured using the Alloy manufacturing process. Patients received lymphodepletion with fludarabine and cyclophosphamide and varying doses of ALLO-647. The median time from enrollment to the start of therapy was three days and 100% of patients received product per specifications. No patients received bridging therapy. The dosing breakdown for the 33 patients included in this data set is as follows: 12 patients treated with a single dose of ALLO-501/501A and FCA90 lymphodepletion: 6 patients treated with a single dose of ALLO-501/501A and FCAless than90 lymphodepletion; 15 patients treated with consolidation dosing of ALLO-501/501A and split lymphodepletion. Seven of 12 (58%) patients receiving the Phase 2 regimen achieved a CR and five maintained a CR through Month 6. Of the five patients who were in CR at 6 months, four remained in CR. The fifth patient had disease progression at 24 months. The median duration of response was 23.1 months with three patients remaining in remission for over 24 months and the longest remaining in remission for over 31 months. Across all 33 patients the CR rate was 42% with 30% maintaining a CR at Month 6. These results indicate complete responses are more common with lymphodepletion regimens containing 90 mg of ALLO-647.. Median duration of response for both the overall population and the patients treated with the Phase 2 regimen was 23.1 months. Across the 33 patients, treatment was generally well tolerated with no incidences of Grade 3 or greater cytokine release syndrome, and no cases of immune effector cell-associated neurotoxicity syndrome or graft versus host disease. Cytopenia and infections were manageable and comparable to the experience with autologous CAR T cell therapies in patients with r/r LBCL. The ALPHA/ALPHA2 Phase 1 trials were designed to assess the safety, tolerability, and preliminary efficacy at increasing dose levels of ALLO-501 and ALLO-501A, allogeneic CAR T cell product candidates that target CD19. In addition to exploring multiple cell doses, these studies evaluated various doses of ALLO-647, Allogene's proprietary lymphodepleting antibody designed to prevent premature rejection of AlloCAR T cells. Allogene is currently enrolling the potentially pivotal Phase 2 ALPHA2 trial of ALLO-501A in LBCL and expects to complete enrollment in 1H2024. The Company expects to open trial sites in Europe, Canada and Australia during 2023.

09:27 EDT Sunrise New Energy granted five patents for silicon anode manufacturing - Sunrise New Energy announced that the China National Intellectual Property Administration has granted the Company five patents, marking significant advancements in the field of silicon anode manufacturing. These patents reinforce the Company's commitment to innovation and position it at the forefront of next-generation lithium-ion battery technology. The granted patents include: AJ220008f-1B Sunrise New Energy Materials Co. 2017111552502: A lithium-ion battery, silicon carbon cathode material used and its preparation method. AJ220018f-1 Sunrise New Energy Materials Co. 2022103961109: A fast ion conductor clad silicon carbon composite material and its preparation method. AJ220025f-1 Sunrise New Energy Materials Co. 2022104011495: A preparation method of low expansion silicon matrix composite. AJ220049f-1 Sunrise New Energy Materials Co. 2022108674134: A preparation method of intermediate phase carbon microsphere-silicon carbon composite anode material. AJ220054f-1 Sunrise New Energy Materials Co. 202210916309X: A template method for the preparation of magnesium-doped hollow silicon carbon composites and its preparation method.

09:26 EDT Kairous Acquisition announces additional contribution to trust account - Kairous Acquisition announced that Kairous Asia has deposited into the Company's trust account an aggregate of $120,000, in order to extend the period of time the Company has to complete a business combination for an additional one month period, from June 16, 2023 to July 16, 2023. The Company issued a promissory note to Sponsor with a principal amount equal to the amount deposited. The promissory note bears no interest and will be converted into the Company's ordinary shares at a price of $10.10 per share at the closing of a business combination by the Company. The purpose of the extension is to provide time for the Company to complete a business combination.

09:17 EDT SOBR Safe signs SaaS agreement with Big Horn County - SOBR Safe signed a software as a service agreement with Montana's Big Horn County to provide twice-daily, passive alcohol screening to the county's probation and pre-trial participants. At over 5,000 square miles, Big Horn is the state's 6th largest in land mass - though just the 30th in population density. Big Horn is representative of the challenges to alcohol testing accuracy and accountability in rural America, an area that makes up 97% of the nation. SOBRsafe and Big Horn County have partnered to create a replicable template for effective court-mandated, passive alcohol screening, outside of major metro areas.

09:14 EDT BeiGene intends to defend patent infringement claims by Pharmacyclics - The company states: "BeiGene is aware that Pharmacyclics LLC has filed a complaint against BeiGene, Ltd. and BeiGene USA, Inc., alleging that BeiGene's BRUKINSA infringes a Pharmacyclics patent issued on June 13, 2023. BeiGene's work is original, and we will vigorously defend against all allegations of patent infringement. It is an unfortunate but rather regular occurrence that companies make allegations that a competitive product potentially infringes their intellectual property rights, even more so in response to a clearly differentiated medicine for cancer patients as BRUKINSA."

09:10 EDT Scilex announces Sorrento's Bankruptcy Court issues temporary restraining order - Scilex, a majority-owned subsidiary of Sorrento Therapeutics, announced that, in connection with Sorrento Therapeutics, Inc.'s ongoing chapter 11 case, the U.S. Bankruptcy Court for the Southern District of Texas has entered a temporary restraining order suspending short-sales of common stock of Scilex Holding Company that Sorrento distributed to its stockholders on or around January 19, 2023. In addition, the Bankruptcy Court ordered certain brokerage firms to provide an accounting of all profits received from naked short-selling of Dividended Scilex Stock and Scilex common stock, including all interest charged to short-sellers, no later than five business days after entry of the order. The Bankruptcy Court's temporary restraining order grants a request by the Official Committee of Equity Security Holders in Sorrento's chapter 11 case, who had asked for the relief. The Official Committee of Equity Security Holders was appointed in

09:09 EDT Wrap Technologies announces addition of multiple new agency customers - Wrap Technologies announced the addition of multiple new agency customers, driving further demand for its proprietary BolaWrap solution across the United States. The BolaWrap device has gained popularity among law enforcement agencies who recognize the need for non-pain-inducing alternatives to better equip their officers for the vast majority of the situations they face. "The momentum we're seeing for our solutions developed with a no-harm guiding principle is a reflection of the recognition by agencies that a majority of law enforcement encounters can be resolved safely and effectively without the use of painful or potentially lethal force," said Kevin Mullins, CEO of Wrap Technologies. "We are thrilled to see such growth in demand for our BolaWrap solution, which demonstrates the effectiveness of our product in the field."

09:08 EDT Toro Corp. announces delivery of second LPG Carrier Dream Arrax - Toro announces that on June 14, 2023, the Company took delivery of the 2015 eco design Japanese-built 5,000 cbm LPG carrier Dream Arrax, which it had agreed to acquire, as previously announced, on April 27, 2023. The acquisition price of $16.95 million was financed in its entirety with cash on hand.

09:07 EDT NaaS spotlights EV innovations at Power2Drive Europe Exhibition - NaaS demonstrated its innovations at the Power2Drive Europe exhibition. The event was held as a part of The smarter E Europe, the largest platform of Europe's energy industry, at the Messe Munchen in Munich, Germany between June 14 and 16, 2023. Power2Drive Europe is an international exhibition for charging infrastructure and E-mobility, shining the spotlight on charging systems, EVs, traction batteries as well as mobility services. As a part of The smarter E Europe platform, the event is collectively expected to feature over 2,400 exhibitors and welcome more than 85,000 visitors. The exhibition marks that NaaS's automatic charging robot has appeared in Europe. Created by the NaaS Automatic Energy Replenishment Solution team, the robot is equipped with an array of sensors that work best in closed environments. From navigation to connecting to the vehicle's charging port, the charging bot can do it all without human input. The driver only needs to summon the bot by tapping on their smart devices.

09:05 EDT LPL Financial: Adam Legate joins broker-dealer, RIA, custodial platforms - LPL Financial announced that financial advisor Adam Legate of VFG Wealth Management and Benefit Solutions has joined LPL Financial's broker-dealer, RIA and custodial platforms. He reported having served approximately $230 million in advisory, brokerage and retirement plan assets, and joins LPL from Royal Alliance, part of the Advisor Group network of broker-dealers. Based in Lexington, Ky., Legate is a 20-year industry veteran who has built his career on the guiding principle that each client is unique and requires a specialized plan to help them meet specific goals and needs. He believes in cultivating long-term relationships with his clients, and many have been with his firm from day one and some are multigenerational.

09:04 EDT Mangoceuticals signs sponsorship agreement with GaS Digital Network - Mangoceuticals announces that it has signed a sponsorship agreement with GaS Digital Network, a well-established digital comedy platform inclusive of 22 podcasts with original content in comedy, politics, music, sports, dating, and self-improvement and with a reach of approximately 5 million listeners per month. GaS Digital will be responsible for promoting and incorporating Mango into each sponsored episode. Along with other promotional content, GaS Digital will work to generate 1 million unique impressions over the span of 2 months. This involves verbally communicating Mango through organic conversations and announcements as well as key product placements. As this deal is also a partnership, MangoRX and GaS Digital may elect to further the relationship with larger brand-focused projects.

09:03 EDT Nano Dimension chairman issues video message to Stratasys shareholders - Nano Dimension (NNDM) released a video in which Yoav Stern, Chairman and CEO of the Company, addresses Stratasys Ltd. (SYSS) shareholders, highlighting the advantages of its special tender offer over Stratasys' merger with Desktop Metal (DM) and the unsolicited proposal from 3D Systems Corp. (DDD). The company said, "In the video, Mr. Stern reiterates the following compelling points regarding Nano Dimension's special tender offer: Nano offers the certainty of cash versus uncertainty of dilution. Nano's $18.00 per share special tender offer delivers certain, near-term premium and all-cash value to Stratasys shareholders. Nano's offer provides more certainty than the Desktop Metal merger or the 3D Systems unsolicited proposal. With approximately $1 billion in cash and cash equivalents, Nano has the financial capacity to complete the special tender offer, which is not subject to Nano shareholders' approval. Nano has a clear vision and path to establish a market leader in Additive Manufacturing and deliver strong bottom-line results for shareholders. Nano will focus on gross margins, EBITDA and earnings-per-share profitability to create lasting value for Stratasys' shareholders. In contrast, Stratasys management continues to make empty promises of becoming "a billion-dollar company," only to deliver further cash burn and value destruction. Change within Stratasys is needed NOW. Stratasys needs better leadership, operators and decision-makers that will optimize the business to realize its potential. Nano has demanded that the Stratasys Board call an Extraordinary General Meeting for the purpose of removing a majority of the Stratasys Board of Directors and replacing them with highly qualified nominees proposed by Nano. Nano believes such action is vital to prevent further value destruction."

09:02 EDT Cardinal Health to build at-Home Solutions distribution center in South Carolina - Cardinal Health plans to build a new distribution center in the Greenville, South Carolina, area, to support its at-Home Solutions business, a home healthcare medical supplies provider serving people with chronic and serious health conditions in the United States. The new facility is at-Home Solutions 11th distribution center nationwide, estimated to bring up to 200 job opportunities to the Greenville region over the next two years. Construction on the new facility will begin this summer; it's estimated to be fully operational within 18 to 24 months.

09:01 EDT Castor Maritime announces the sale of M/V Magic Twilight for $17.5M - Castor Maritime announces that on June 2, 2023, the Company entered into an agreement with an unaffiliated third party for the sale of the M/V Magic Twilight, a 2010-built Kamsarmax bulk carrier, at a price of $17.5 million. The conclusion of the sale agreement is subject to the execution of definitive documentation customary for this type of transaction. The vessel is expected to be delivered to its new owner during the third quarter of 2023. The Company expects to record during the third quarter of 2023 a net gain on the sale of the M/V Magic Twilight of approximately $4.0 million, excluding any transaction related costs.

08:51 EDT Conduent teams with RelativityOne to expand eDiscovery capabilities offering - Conduent announced it is expanding its suite of eDiscovery technology solutions with the addition of Relativity's cloud-based eDiscovery solution, RelativityOne. With the integration of RelativityOne, Conduent provides clients enhanced data protection with a single, secure SaaS platform that spans the full breadth of eDiscovery - from legal hold through to production. "With the digitization of nearly everything, there is now a massive information load that makes it more complicated to ensure legal compliance and accuracy of information during eDiscovery. Technology solutions must capture complex data, host data securely, integrate into existing workflows and provide the ability to interpret the data," said Sal Mancuso, Senior Director of eDiscovery Operations & Products at Conduent. "With the integration of RelativityOne, Conduent's clients can work with experienced project managers to implement customized workflows to ensure efficient review and consistency across all matters."

08:50 EDT Freeview Australia entered renewal agreement to license Adeia's IP portfolio - Adeia announced that Freeview Australia Limited, the free digital television service that presents and promotes free-to-air channels and content, has entered into a multi-year renewal agreement to license Adeia's media intellectual property, IP, portfolio. Freeview Australia plays a critical role in providing Australian audiences with frictionless, cost-free, live and on-demand access to popular local & international content offered by Australia's major free-to-air broadcasters. "The world-class hybrid broadcast and broadband TV service offered by Freeview Australia provides viewers with seamless access to high-quality entertainment experiences, extending the reach of free-to-air players while offering Australian consumers the convenience of accessing desired content when and where they choose," said Dr. Mark Kokes, Adeia's chief licensing officer and general manager, media. "Adeia's media IP portfolio enables viewers to intuitively navigate Freeview's vast library and find the content they desire."

08:49 EDT Cutera announces new U.S. FDA clearance of AviClear - Cutera announces a new U.S. Food and Drug Administration Clearance of AviClear as a long-term treatment for mild to severe inflammatory acne vulgaris. This is the first acne therapy to claim long term effectiveness for mild, moderate and severe acne.

08:47 EDT Allstate estimates catastrophe losses for May $885M - The Allstate Corporation announced estimated catastrophe losses for the month of May of $885 million or $699 million, after-tax. May month catastrophe losses include 12 events estimated at $893 million, with approximately 70% of the losses related to two wind and hail events, partially offset by favorable reserve reestimates for prior events. Total catastrophe losses for April and May were $1.68 billion, pre-tax. During the month of May, the Allstate brand implemented auto rate increases of 9.3% across 15 locations, resulting in total brand premium impact of 1.6%. "Allstate continued to implement significant auto insurance rate actions as part of our comprehensive plan to improve profitability. Since the beginning of the year, rate increases for Allstate brand auto insurance have resulted in a premium impact of 4.9%, which are expected to raise annualized written premiums by approximately $1.28 billion," said Jess Merten, Chief Financial Officer of The Allstate Corporation. Our implemented auto rate exhibit has been posted on allstateinvestors.com.

08:46 EDT Glass Lewis recommends First Foundation shareholders vote for change in board - Driver Management Company, a sizable stockholder of First Foundation, announced that leading independent proxy advisory firm Glass, Lewis & Co. recommended that First Foundation stockholders vote for change in the boardroom. In its report, Glass Lewis recommended stockholders vote FOR Driver nominee Allison Ball to First Foundation's board of directors at the Company's upcoming Annual Meeting of Stockholders to be held on June 27, 2023. In its report recommending First Foundation stockholders vote for change on the Board, Glass Lewis: Agreed with Driver's assessment of First Foundation's poor TSR and financial underperformance; Raised serious concerns about the Company's initial decision to reject Driver's Nomination Notice as an entrenchment maneuver to avoid accountability; Noted concern regarding the Board's apparent abdication of responsibilities to management and lack oversight; Believed that Driver Nominee Allison Ball would bring relevant skills to the Board; Highlighted Driver's record of a willingness to work constructively with banks; Concluded there was a clear case for change on First Foundation's Board.

08:41 EDT Star Equity reacts to second adjournment Firsthand Technology meeting - Star Equity Fund is an investment fund focused on unlocking shareholder value and improving corporate governance at its portfolio companies. Star Equity Fund owns 6.2% of the common stock of Firsthand Technology Value Fund. Star Equity said the following: SVVC Twice Failed to Reach a Quorum for its Annual Meeting. SVVC's 50% Vote Threshold Is Designed to Discourage Shareholders from Nominating Qualified Directors. The Incumbent Board Appears Indifferent To Shareholder Frustration and Detached From Shareholders' Interests. The Company's Inability to Reach a Quorum for its Annual Meeting Threatens Delisting from NASDAQ. The Company Has Not Disclosed Either the Voting Results or Plans to Reconvene the Annual Meeting.

08:39 EDT Blacboxstocks announces $8.5M stake in Evtec as move to planned merger - Blackboxstocks announced that it executed a Securities Exchange Agreement with Evtec Group Limited on June 9 The Securities Exchange Agreement provides for a mutual investment between the two companies as an initial step towards completing the planned merger between Blackbox and Evtec Group Limited, Evtec will issue 2.4M hares of a newly created Series B Convertible Preferred Stock in exchange for 4,086 newly issued preferred shares of Evtec Group Limited. The Series B Preferred Stock is non-voting and will be convertible into common stock on a one-for-one basis only after receiving stockholder approval. The preferred shares issued by Evtec Group are non-voting and convertible into common shares on a one-for-one basis immediately prior to, or at the time of, the merger between the companies. As a result of the execution of the Securities Exchange Agreement, Blackbox stockholders' equity will increase by $8.52M, enabling the company to regain compliance with the $2.5M minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550. Evtec Group is the parent of Evtec Automotive Limited and an affiliate of Evtec Aluminium. Evtec Aluminium was not a party to the Securities Exchange Agreement but will be acquired as part of the merger.

08:38 EDT KULR Technology expands SafeCASE line for electric bikes - KULR Technology Group has expanded its SafeCASE product line for the consumer e-mobility market. KULR is bringing to the consumer market the same patented technology it provides NASA to protect astronauts on the International Space Station and manned space missions. With over 300 million e-bikes alone in use around the world today and growing at double-digit percentages, the threat of battery related fires is real and growing. When battery fires occur, they can immediately reach temperatures in excess of 1,000 degrees Celsius. They are typically difficult to extinguish even for professional firefighters. In 2022, in New York City alone, rechargeable batteries caused 219 fires, with 147 injuries, 6 deaths and millions of dollars in damages.

08:37 EDT CarGurus announces 'success' of Digital Deal solution - CarGurus marked a milestone year in collaboration with over 2,250 dealer partners who fueled the success of its Digital Deal solution as one of the company's fastest-growing offerings. Launched last year, the digital retail innovation responds to dealers' desire to meet the needs of today's shoppers with greater efficiency, delivering leads that are up to 5.3x more likely to close1 at 2x higher customer satisfaction rates.

08:36 EDT Arista Networks down 5% in pre-market trading - Shares of Arista Networks are down $9.08, or 5%, to $160.00 in pre-market trading and the early weakness is being attributed to cautious comments from boutique firm Cleveland Research, trading contacts tell The Fly.

08:34 EDT CorMedix announces strategic initiative with Boston Medical Center - CorMedix announced its strategic initiative with Boston Medical Center to enhance patient safety and reduce health disparities in structurally marginalized populations at risk for bloodstream infections while undergoing dialysis. It is estimated that 25 - 33% of chronic hemodialysis patients with catheters will experience Catheter Related Bloodstream Infections and are three times more likely to experience serious complications, including high mortality rates, within the first few months of dialysis due to CRBSIs. CRBSIs disproportionately impact minority and low-income patient populations on dialysis, who may experience a higher rate of central venous catheter use, resulting in higher medical costs, prolonged hospital stays, increased antimicrobial resistance and higher mortality. This real-world data initiative will evaluate the use of a novel antimicrobial catheter lock solution to reduce the incidence of CRBSIs in patients receiving dialysis through a CVC. The goal of this initiative is to increase healthy outcomes for patients disproportionately impacted by CRBSIs. CorMedix and Boston Medical Center will assess the incidence and scope of CRBSIs, care inequities in patients experiencing CRBSIs, total potential costs of treatment, and CRBSI-related readmissions. This assessment will form the baseline from which CorMedix and Boston Medical Center will evaluate the impact that infection prevention can have on reducing the health disparities that structurally marginalized patient populations often face.

08:33 EDT ClearSign announces reincorporation in the State of Delaware - ClearSign Technologies announced that the company has reincorporated in the State of Delaware from Washington State. The Reincorporation was previously approved by the board of directors of the company, and subsequently approved by the shareholders of the company at the company's Annual Meeting of shareholders held on June 6. ClearSign is now subject to the General Corporation Law of the State of Delaware.

08:24 EDT Hepion says DSMB issues 'study may proceed' clearance on ASCEND-NASH trial - Hepion Pharmaceuticals announced that the Data and Safety Monitoring Board has met to review the current data for the ASCEND-NASH Phase 2b trial and has issued a "study may proceed without modification" clearance. This, the first planned DSMB meeting, occurred on schedule, and all labs, EKGs, adverse events, and protocol deviations were reviewed, focusing on any potential safety signals from the placebo-controlled trial. Hepion is on track to complete enrollment in ASCEND-NASH in the first quarter of 2024, and the initial subjects are now approaching the later stages of the 12-month trial.

08:16 EDT Kaival launches distribution of BIDI Stick in over 900 Kwik Trip, Mapco stores - Kaival Brands Innovations Group announced the initial shipment of BIDI Sticks to over 900 Kwik Trip and Mapco locations, with a ramp up to over 1,200 locations planned for the remainder of this year, with Kwik Trip representing over 900 of those locations.

08:15 EDT Trinity Capital increases dividend 2.1% to 53c per share - Trinity Capital declared a cash dividend of 53c per share with respect to the quarter ending June 30, 2023, consisting of a regular quarterly dividend of 48c per share and a supplemental cash dividend of 5c per share. The dividend represents an increase of 2.1% over the regular dividend declared in the prior quarter. The company's Board of Directors has authorized the supplemental cash dividend in order to comply with regulated investment company tax requirements for distributing its undistributed taxable income from fiscal 2023. The payment date is July 14 and the record date is June 30.

08:12 EDT Magnite introduces Magnite Access, an omnichannel audiences, data, supply suite - Magnite introduced Magnite Access, a suite of omnichannel audience products that make it easier for display, online video, and streaming media owners-and their advertising partners-to maximize the value of their data assets. As the center of gravity for audience and identity shifts closer to the sell side, Magnite Access empowers publishers to manage, create, and transact audience segments in a variety of ways. "The industry is undergoing a major shift as audience and identity frameworks migrate closer to the sell-side," said Adam Soroca, Chief Product Officer at Magnite. "This presents an opportunity for media owners to embrace new ways of activating audience data at scale. Magnite Access ensures we are well-positioned to provide our clients with omnichannel audience products across multiple formats, such as streaming and display, as well as multiple demand sources. The expansive breadth of deterministic and probabilistic tools within Magnite Access provides sellers and buyers with a comprehensive, high-precision solution. Magnite's deep relationships with premium publishers and advertisers give us a unique vantage point to create solutions that add value for all parties."

08:10 EDT OrthoPediatrics announces election of George Dyer to board of directors - OrthoPediatrics announced that George Dyer, MD was elected to the Company's Board of Directors at its Annual Meeting of Stockholders held on June 14, 2023. The newly elected Dr. Dyer along with reelected directors David R. Pelizzon, Harald Ruf and Terry D. Schlotterback will serve three-year terms expiring at the 2026 Annual Meeting of Stockholders. George S. M. Dyer, MD is currently an attending upper extremity surgeon on both the Hand and Upper Extremity Service and the Orthopedic Trauma Service at Mass General Brigham in Boston, Massachusetts.

08:10 EDT Nemaura Medical to exhibit, provide live product demos at ADA sessions - Nemaura Medical will exhibit and provide product demonstrations of its non-invasive daily-wear glucose sensor platform at the 83rd Scientific Sessions of the American Diabetes Association. The meeting will be held June 23-26, 2023 in San Diego.

08:09 EDT Helocyte announces $3.22M grant from NCI for Triplex Phase2 trial program - Helocyte, a subsidiary of Fortress Biotech, announced that the National Cancer Institute, NCI, has awarded a $3.22 million grant to City of Hope for clinical studies of Triplex, a cytomegalovirus vaccine being developed by Helocyte and City of Hope. This competitive award will fund two planned multicenter, placebo-controlled, randomized Phase 2 studies to evaluate the potential safety and immunological response of Triplex and its ability to enhance CMV-specific T cell immunity in stem cell donors to reduce the risk of CMV events in recipients of allogeneic hematopoietic cell transplant, HCT. Lindsay Rosenwald, M.D., Fortress' Chairman and Chief Executive Officer, said, "We are very excited that Triplex, being progressed by Helocyte, is the subject of this NCI grant which will enable the further evaluation of the vaccine's potential to control CMV in patients undergoing high-risk HCT. CMV is a common opportunistic infection in transplantation, directly impacting post-transplant outcomes and patient mortality. The trial will build upon the growing patient database of Triplex, which has already been dosed safely in over 150 patients and volunteers, and is the subject of multiple other ongoing and planned studies."

08:08 EDT Tracon announces enforcement action to collect arbitration award from I-Mab - TRACON Pharmaceuticals announced that it has commenced court proceedings in Hong Kong and the Cayman Islands to enforce an April 2023 arbitration award against I-Mab for approximately $23.0 million, plus interest. On June 14, 2023, TRACON served I-Mab with an order of the High Court of the Hong Kong Special Administrative Region provisionally allowing TRACON to begin enforcing that award as soon as July 13, 2023 in Hong Kong. "I-Mab issued a press release acknowledging that the arbitration award is final and binding, and stating that it would confirm the award promptly, so we are disappointed they are delinquent in paying the award," said Charles Theuer, M.D., Ph.D., President and CEO of TRACON. "We commenced these judicial proceedings to collect the full amount I-Mab owes, including accumulating interest."

08:07 EDT Reinsurance Group sees medium-term EPS growth of 8%-10% CAGR - Sees 11%-13% ROE. Comments taken from investor presentation slides. Reference Link

08:06 EDT Aemetis India subsidiary on schedule with biodiesel shipments to OMC customers - Aemetis announced that its Universal Biofuels subsidiary in India is on schedule with biodiesel shipments to the three government-owned Oil Marketing Company customers with $27 million of the $34 million of second quarter contracted deliveries already completed. The combined orders for Q2 2023 comprised about 8 million gallons of biodiesel and future volumes are expected to be increased as OMC procurement processes continue to improve.

08:05 EDT Daxor announces the launch ezBVA Lab services - Daxor announces the launch of a new service designed to drive faster adoption and provide greater prescriber access to Daxor's innovative blood volume analysis technology, BVA. Daxor's ezBVA Lab is a state-of-the-art CLIA certified facility located at Daxor's Oak Ridge facility that provides on-demand, next day blood volume analysis results. "Daxor's ezBVA Lab requires no capital investment from our customers while easily integrating into workflow with eligible reimbursement by both private and public insurance," said Michael Feldschuh, CEO of Daxor Corporation. "We are excited to provide a simpler, cost-effective solution for hospitals and clinicians to adopt our technology who do not have our analyzer systems available in their lab but will instead utilize Daxor's paid lab service, so providers can achieve optimal fluid management for their patients."

08:05 EDT Xiao-I launches U.S. subsidiary Xiao-I Plus - Xiao-I announced the Company launched a U.S. subsidiary, Xiao-I Plus Inc., marking another significant milestone for its global expansion strategy. On June 10th, Xiao-I held a ceremony at the University of Maryland to celebrate the establishment of its Xiao-I Plus subsidiary. The U.S. subsidiary representative Ms. Jie Cheng, Chief Advisor Mr. Zhongren Yu, and Xiao-I's collaborating scientists were among those present. The establishment of the subsidiary is in line with one of the Company's four core strategies - expanding its global footprint. Bolstered by strong operations in China, Xiao-I focuses on cognitive intelligence with consistent innovations to explore high-potential industries and international markets in support of serving global customers and pursuing higher revenue levels. With this subsidiary, Xiao-I will continue to strengthen its research and development of core cognitive AI technologies and expand the international market to accelerate the industry's development. Currently, Xiao-I offers global users with multi-language versions of AI products and solutions, including English, Traditional and Simplified Chinese as well as others. These products also have quick customization capabilities for multi-language projects. In face of the North American market, Xiao-I aims to expand and integrate with mature products such as chatbot and robotic process automation based on its large language model. This strategy includes initiatives to combine cognitive intelligence technology with real-life scenarios, data, and user needs to produce commercialized and customizable product lines that are deliverable internationally.

08:03 EDT Delta Air Lines resumes quarterly dividend at 10c per share - Delta Air Lines' Board of Directors declared a quarterly dividend of 10c per share. The dividend is payable to shareholders of record as of the close of business on July 17, 2023, and will be paid on August 7, 2023. This resumption of Delta's quarterly dividend following the suspension of the program in March 2020 reflects Delta's progress on its three-year financial plan, including over $10B of debt repayment over the last two years.

08:03 EDT Femasys appoints Keith Kendall, Alistair Milnes to board of directors - Femasys has appointed Keith Kendall andAlistair Milnes to its board of directors. Messrs. Kendall and Milnes will be replacing Mr. John Dyett, who currently serves as Co-CEO of Salem Partners, LLC and Salem Partners Wealth Management, LLC and Mr. John Adams, formerly served as CEO and President of Adams Respiratory Therapeutics, who both have served as members of Femasys' board of directors for over eight years. Mr. Kendall will also replace Mr. Dyett as Audit Committee Chair. Kendall serves as Founder and CEO at KSquared Strategic Advisors, a firm that provides strategic, corporate development and capital markets advisory services. Alistair Milnes serves as Chief Operating Officer at Bicycle Therapeutics, a clinical-stage biopharmaceutical company.

07:54 EDT White Gold announces fully funded 2023 exploration program - White Gold announced plans for its fully funded 2023 exploration program on its district scale 350,000 hectare land package, representing over 40% of the emerging White Gold District in Yukon, Canada. The 2023 program is designed to further evaluate targets on the Betty and JP Ross properties and to perform maiden diamond drilling on the Cali target located on the Nolan property. Other regional exploration work includes maiden rotary air blast drilling on the Wolf and Toonie properties and a significant early-stage exploration program to identify and advance other targets on the Company's extensive and under explored land package in which the Company has made several high grade gold discoveries in addition to significantly increasing resources at the Company's flagship White Gold Project which comprises 16 million tonnes averaging 2.23 g/t Au for 1,152,900 ounces of gold in the Indicated Resource category and 19 million tonnes averaging 1.54 g/t Au for 942,400 ounces of gold in the Inferred Resource category and remains open for expansion. Highlights: Exploration diamond drilling totalling 3,200m planned on three targets - Betty Ford, Vertigo and Cali. Betty Ford - Testing for porphyry at depth beneath the mineralized breccia, plus potential feeder contact/structure identified through VLF-EM ground geophysics. Recent drilling at Betty Ford intersected 3.46 g/t Au over 50.0m in hole BETFD21D003 and 8.94 g/t gold over 18.29m in hole BETFD22RC004. Vertigo - First drilling since 2019 with program designed to test a new structural interpretation which includes multiple mineralized vein sets not previously drill tested. 2018 and 2019 drilling highlights at the Vertigo include 23.44 g/t Au over 24.38 m, 12.25 g/t Au over 15.24 m, 9.46 g/t Au over 22.86 m, and 11.64 g/t Au over 5.34 m. Cali - Maiden diamond drilling with widely spaced holes testing large gold and multi-element soil anomaly located along the regional Sixtymile-Pika Fault. Maiden RAB drill programs totalling 800 m to test gold targets on the Wolf and Toonie properties. Induced Polarization - Resistivity ground geophysical surveys over the large early-stage Bridget and Hayes Copper-Molybdenum porphyry targets located on the Pedlar and Hayes properties in close proximity to the large Casino porphyry deposit. Regional exploration on other properties includes geological mapping and prosecting, soil geochemistry surveys, and ground magnetics and VLF-EM surveys to generate new targets for future drill testing. Additional detail on the various components of the program to be released in due course. A corporate update webinar has been arranged for management to present additional detail on the Company's fully funded 2023 exploration program. Event and registration details to be provided.

07:38 EDT Skeena Resources announces decision on application for leave to appeal - Skeena Resources announces that Justice Fisher of the Court of Appeal for British Columbia has granted the Company's application for leave to appeal from the decision of the Supreme Court of British Columbia, which dismissed the Company's appeal from the February 7, 2022 decision of the Chief Gold Commissioner. The Chief Gold Commissioner had concluded that Richard Mill, and not Skeena, owns the mineral rights to materials contained in the Albino Lake Storage Facility at Eskay Creek. The decision allows Skeena's appeal to proceed. The court decided that Skeena's appeal raises legal issues of sufficient merit to warrant review by the Court of Appeal, and that the proper interpretation of the relevant legislation will be important to the resource extraction industry and other stakeholders. No date has been set for the hearing of Skeena's appeal. The Company will provide updates when more is known. The material contained in the Albino Lake Storage Facility is not part of the Company's Resource or Reserve Statements for Eskay Creek nor has it been included in any studies, including the September 2022 Feasibility Study for the Eskay Creek Project.

07:36 EDT Amesite announces launch of professional upskilling courses at CMU - Amesite announces it has launched professional upskilling courses in partnership with Central Michigan University, CMU, spanning topics from 'Introduction to Additive Manufacturing - 3D Printing' to 'Workplace Wellness'. Amesite Founder & CEO, Ann Marie Sastry Ph.D. commented, "This launch is a huge initiative and the perfect example of a university partner really expanding offerings to meet the needs of professionals around the world. By leveraging our Version 6 platform and our latest integration of the GPT-4 technology, our Partners can launch offerings out-of-the-box on state of the art technology, providing the best experience the market has to offer. We are grateful for this partnership with Central Michigan University and look forward to furthering their global upskilling initiatives."

07:35 EDT Earthstone Energy to acquire Novo Oil & Gas Holdings for $1.5B - Earthstone Energy (ESTE) has entered into an agreement to acquire Novo Oil & Gas Holdings, a privately-held Delaware Basin focused E&P company backed by EnCap Investments, for $1.5 billion. Concurrently, Northern Oil and Gas, Inc. (NOG) will acquire working interests equal to a pro-rata 33 % of the oil and gas assets of Novo for $0.5 billion from Earthstone, resulting in a $1.0 billion purchase price net to Earthstone for the retained 66 2/3 % interest. Consideration at closing will be subject to customary purchase price adjustments. The effective date of the Novo Acquisition is May 1, 2023, and closing is anticipated to occur in the third quarter of 2023, subject to customary closing conditions. The Novo Acquisition is expected to be funded with cash on hand and borrowings under the Company's senior secured revolving credit facility. In conjunction with the Novo Acquisition, Earthstone has secured $250 million of incremental commitments from existing lenders. This increases elected commitments under Earthstone's Credit Facility from the current $1.4 billion to $1.65 billion and provides for ~$1.2 billion in undrawn commitments at closing based on $452 million debt outstanding as of March 31, 2023. Earthstone intends to maintain its five operated drilling rigs post-closing. Given that Novo's inventory immediately competes for capital, Earthstone intends to move one of its two drilling rigs currently operating in the Midland Basin to the Delaware Basin to focus on the Novo assets. The net result will be Earthstone having four rigs operating in the Delaware Basin and one in the Midland Basin post-closing. The Novo Acquisition and revised development plan continue Earthstone's evolution over the past several years, with its drilling inventory and development program now heavily weighted towards the highly economic northern Delaware Basin assets. Recent Non-Core Asset Sales Earthstone sold certain non-core assets in the Midland Basin for cash proceeds of approximately $56 million on May 31, 2023. The divested assets included production of approximately 530 Boepd and acreage comprising 32 short lateral drilling locations. Earthstone will continue to consider other non-core asset sales as appropriate in the future. Impact on Earthstone The estimated impact on Earthstone from the Novo Acquisition, recent non-core asset sale, and expected capital program is described below. Earthstone intends to provide updated guidance in conjunction with the closing of the Novo Acquisition. Production: 4Q 2023 production expected to increase by 30,000-35,000 Boepd relative to the current operating plan and guidance 2024 total Earthstone production expected to decline moderately compared to 4Q 2023 production, with the production profile flattening out in 2H 2024 Capital Expenditures: No change to the 2023 capital expenditures guidance of $725-775 million Free Cash Flow: Free Cash Flow in 2024 expected to increase by more than 60% given no change to capital expenditures, improved capital efficiency with the Novo drilling inventory and increase in production Drilling Inventory: Delaware Basin acreage position increases by approximately 11,300 net acres to approximately ~56,000 net acres Drilling inventory increases 24% to 1,020 gross locations, with approximately 70% of locations in the Delaware Basin Extends inventory life to approximately 13 years with a five-rig drilling program Debt Metrics and Liquidity: Forecasted leverage at year-end 2023 of 1.1x Last Quarter Annualized Adjusted EBITDAX Moderate increase to near-term leverage counterbalanced by targeted sub-1.0x leverage within 12 months Approvals The Conflicts Committee of the Board of Directors of Earthstone approved and recommended the Novo Acquisition to the Board of Directors of Earthstone, which has approved the Novo Acquisition. No further approvals are required. Revised Commodity Hedge Positions In conjunction with the signing of the Novo Acquisition, Earthstone increased its commodity hedge positions, entering into hedge positions accounting for more than 50% of Novo's proved developed producing oil and gas reserve volumes through 2024.

07:33 EDT Endo: Par Pharmaceutical begins shipping generic version of Takeda's Dexilant - Endo International (ENDP) announced that one of its operating companies, Par Pharmaceutical, has begun shipping dexlansoprazole 30 mg capsules, a generic version of Takeda's (TAK) Dexilant. This additional dosage strength rounds out the product family, now with both 30 mg and 60 mg delayed-release capsules.

07:32 EDT Thorne HealthTech's blood sampling device earns CE Mark certification in EU - Thorne HealthTech's NanoDrop device has received a CE Mark certification and has successfully fulfilled the European Union's relevant performance, safety, and product requirements. NanoDrop brings virtually painless blood collection to decentralized clinical trials and at-home diagnostic testing. NanoDrop's CE mark certification allows individuals to use the device in their home.

07:21 EDT LVMH, Epic Games partner for Maisons' creative pipeline, experiences - In a Wednesday press release, LVMH said, "At the Viva Technology show, LVMH announced a partnership with Epic Games, creator of Fortnite and Unreal Engine, to transform the Group's creative pipeline and bring customers new types of immersive products discovery experiences. This strategic partnership will empower LVMH and its Maisons to further utilize Epic's powerful 3D creation tools to offer experiences like virtual fitting rooms and fashions shows, 360 product carousels, augmented reality, creation of digital twins and more. These tools, including Unreal Engine, Reality Capture, Twinmotion, and MetaHuman technology will help LVMH unlock significant growth opportunities. With a resolutely future-facing spirit, LVMH and its Maisons have continually updated their offering to engage with new practices while respecting their timeless assets and heritage. This same ethos guides the partnership forged with Epic Games. LVMH will be able to leverage the world-renowned expertise of Epic to enrich the experiences proposed to its customers in virtual worlds, tightening an alignment with the Group's core strengths in the real world - the inimitable know-how of its production workshops and ownership of its networks of stores. What's more, collaborating with Epic will expand the expertise of LVMH teams, reflecting the priority the Group places on nurturing the digital acculturation of its people."

07:15 EDT Verisk Analytics announces FCIC utilizes its CL VIN Decode solution - First Chicago Insurance Company, FCIC, a member of the Warrior Insurance Network, WIN, is refining its commercial auto underwriting with robust vehicle data from Verisk, a leading global data analytics and technology provider. The insurer is leveraging Verisk's new commercial lines, CL, VIN Decode solution to gain a more robust understanding of risk unique to commercial and specialized vehicles. With an individual Vehicle Identification Number, the solution delivers information on more than 50 detailed vehicle attributes, such as year, make, model, weight, engine, and transmission, seamlessly into First Chicago's underwriting workflow.

07:14 EDT Mirasol terminates agreement to option Coronacion Copper-Gold Project - Mirasol Resources has regained 100% control of the Coronacion High-Sulfidation Epithermal copper-gold project in Chile following termination of the Option and Farm-in Agreement with First Quantum Minerals announced on October 7, 2019. "First Quantum's inability to meet the minimum drilling requirement under the Agreement provided the opportunity for us to regain 100% unencumbered control over the highly prospective Coronacion Project. Evidence of extensive, closely spaced definition drilling over a 2.25 km2 area at First Quantum's Vendaval Project directly across the Argentine border greatly increases the significance of the drill-ready targets at Coronacion", Mirasol's President, Tim Heenan, commented. "Apart from Coronacion, there are other exceptional prospects in the immediate vicinity, including our Altazor HSE/Porphyry Gold/Copper Project, adding to the district potential of this region in northern Chile." Since the start of the partnership, First Quantum has invested approximately $1 million in exploration on the Coronacion Project, including cash payments of $175,000 to Mirasol.

07:13 EDT Stellantis Venture invests in 10 startups, 1 mobility venture fund - Stellantis Ventures, the corporate venture fund of Stellantis N.V., has been formed to support and amplify the execution of Dare Forward 2030 strategic plan. Ten startup companies and one mobility venture fund have been considered so far as its first key investments. Three of the projects backed by Stellantis Ventures are launching this year, validating the fund's mission to accelerate deployment of innovative, customer-centric mobility technologies and support Stellantis' Dare Forward 2030 efforts in leading the change to a more sustainable mobility and better in-vehicle experience for all customers. "Transforming Stellantis into a mobility tech company means we need to have the mindset of a startup, focused on our customers and working with a dash of impatience," said Ned Curic, Stellantis Chief Technology Officer. "We are using the strength of Stellantis Ventures to connect with companies that are developing cutting-edge technology that we believe can transform the in-cabin experience and improve the mobility sector, for our customers and for society as a whole."

07:11 EDT High Street Logistics and Altus Power announce strategic partnership - Altus Power announced an exclusive strategic partnership to develop and construct clean electrification solutions at High Street's industrial owned real estate properties nationwide. Altus Power and High Street plan to deploy solar across High Street's currently owned portfolio of 144 industrial and logistics assets totaling over 18.2 million square feet. In addition to the building-sited, locally generated solar power, Altus Power and High Street plan to implement battery storage and fleet electric-vehicle charging infrastructure across the portfolio. High Street's industrial properties offer large, unused rooftops which are well suited for Altus Power's commercial-scale solar arrays. High Street will also become one of the first Altus Power customers to benefit from its AI-powered Carbon Dashboard. The Carbon Dashboard is a comprehensive software-as-a-service platform developed by Altus Power to deliver clean power usage insights to clients as they strive to achieve ambitious net-zero goals. As new solar arrays are completed, High Street can use the Carbon Dashboard to monitor savings from each individual solar asset and additionally to measure carbon emitted across its portfolio, which can assist in their reporting to real estate ESG benchmarks such as GRESB and other ESG reporting protocols.

07:10 EDT Aveanna appoints Debbie Stewart as Principal Accounting Officer - Aveanna has appointed Debbie Stewart, Vice President, and Chief Accounting Officer, to serve as Senior Vice President and Principal Accounting Officer, effective July 7, 2023. Ms. Stewart brings more than 15 years of accounting and financial experience to Aveanna. Ms. Stewart joined the Aveanna management team in September 2021 and is responsible for accounting, tax, treasury, audit, and SEC reporting.

07:10 EDT Renalytix announces accepted abstracts at upcoming ADA, AANP conferences - Renalytix announced that three scientific abstracts have been accepted at the upcoming American Diabetes Association, ADA, 83rd Scientific Sessions in San Diego, California and another abstract has been accepted at the American Association of Nurse Practitioners, AANP, National Conference in New Orleans, Louisiana. American Diabetes Association 83rd Scientific Sessions presentations will be displayed over three days June 24-26, 2023: Late-breaker Presentation: "Clinical Impact of Risk Profiling with KidneyIntelX on DKD Progression in a Large Integrated Health Care System." Poster presentation: "Extended Validation of KidneyIntelX(TM) in Diabetic Kidney Disease." Poster presentation: "Cost of Care for Patients with Diabetic Kidney Disease in Veterans Health Administration." An American Association of Nurse Practitioner conference presentation will be displayed June 22-24, 2023, and moderated over three days: Poster presentation: "Understanding Patient Receptivity Towards Receipt of Prognostic Risk Score for Diabetic Kidney Disease" will be presented by Renalytix on behalf of the Patient Care Navigation Team at Mount Sinai Health System and focused on the significant impact KidneyIntelX can have on patients' enhanced understanding of kidney disease and motivation to make lifestyle changes, as well as the role nurse practitioners play in influencing patient behavior and clinical outcomes.

07:09 EDT Aldeyra's reproxalap study receives statistical significance for all endpoints - Aldeyra Therapeutics announced positive top-line results from the Phase 3 INVIGORATE-2 Clinical Trial of 0.25% reproxalap ophthalmic solution, reproxalap , an investigational new drug, in patients with allergic conjunctivitis. The clinical trial successfully achieved statistical significance for the primary endpoint and all secondary endpoints. "Consistent with the results of the Phase 3 INVIGORATE Trial and in conjunction with a number of successful Phase 2 and Phase 3 clinical trials in dry eye disease, achievement of the primary endpoint and all secondary endpoints in INVIGORATE-2 supports the potential of reproxalap as a treatment for inflammatory diseases of the ocular surface," stated Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra. "We believe that the rapid-onset activity of reproxalap evidenced in the INVIGORATE clinical trials may offer hope to allergic conjunctivitis patients who are today not adequately treated, and also to dry eye disease patients, up to 50% of whom suffer from ocular allergy."

07:08 EDT Tonix Pharmaceuticals announces publication of Phase 3 RELIEF trial results - Tonix Pharmaceuticals Holding announced that previously disclosed results from the Phase 3 RELIEF study of TNX-102 SL for the management of fibromyalgia have been published in the peer-reviewed journal Arthritis Care & Research, an official journal of the American College of Rheumatology. In RELIEF, treatment with TNX-102 SL was associated with significant reductions in daily pain and was generally safe and well tolerated in patients with fibromyalgia. Secondary results also suggest that treatment with TNX-102 SL can improve sleep and reduce fatigue, which together with pain are recognized as core fibromyalgia symptoms. TNX-102 SL is a novel, non-opioid, centrally-acting analgesic, intended to be taken once daily at bedtime. The paper, titled, "Efficacy and Safety of TNX-102 SL for the Treatment of Fibromyalgia: Results From the Randomized, Placebo Controlled RELIEF Trial," includes data demonstrating that TNX-102 SL met its pre-specified primary endpoint in the Phase 3 RELIEF trial, significantly reducing daily pain compared to placebo in participants with fibromyalgia. Also, in an exploratory analysis, when the primary endpoint was analyzed as a greater than or equal to30% pain responder analysis, there was a higher rate of responders to TNX-102 SL than to placebo. TNX-102 SL at 5.6 mg also showed activity in key secondary endpoints demonstrating improvements in sleep quality, mitigation of fatigue and fibromyalgia-specific global symptomatic and functional recovery. Early discontinuation rates were similar for TNX-102 SL and placebo. In addition, TNX-102 SL was well tolerated with the most common adverse event from active treatment being oral numbness or hypoaesthesia, an administration site reaction that is typically transient, was never rated as severe, and lead to only one discontinuation. Tonix is currently enrolling in a potentially confirmatory, registration-enabling Phase 3 study. Topline results are expected in the fourth quarter of this year.

07:06 EDT Nokia partners with DXC Technology to launch DXC Signal Private LTE, 5G - Nokia (NOK) and DXC Technology (DXC) announced the availability of DXC Signal Private LTE and 5G, a managed secure private wireless network and digitalization platform solution that helps industrial enterprises digitally transform their operations. As part of a global, strategic partnership, the two companies have made a commitment to providing world-class private wireless networking solutions that will propel organizations into the future. Together, DXC and Nokia offer companies a powerful solution to organizations that require high-bandwidth, low-latency wireless networks to support increased automation, enhanced flexibility, operational technology data processing, and privacy needs. Brian Miller, Global Lead, Applications, DXC Technology, said: "Our customers are partnering with DXC in unlocking the full potential of private wireless networks to drive their digital transformations in environments where traditional networks can't scale. Our partnership with Nokia allows us to deliver an innovative and future-proof solution, empowering our customers to achieve greater operational efficiency, IT and OT convergence, and maintain robust data privacy."

07:06 EDT Cognyte expects 'significant' gross margin improvement for FY23 - "We are expecting significant gross margin improvement for the full year primarily due to an increase in software revenue. I am also very pleased with the strong cash flow in the first quarter and we are now expecting positive cash flow from operations for the full year," said David Abadi, Cognyte's chief financial officer.

07:04 EDT CytoSorbents announces independent DSMB recommends completion of STAR-T trial - CytoSorbents announced that it has received the recommendation from the independent Data and Safety Monitoring Board, DSMB, following the second scheduled safety review, to complete the pivotal Safe and Timely Antithrombotic Removal - Ticagrelor, STAR-T, trial as planned without any modifications. Dr. Efthymios N. Deliargyris, Chief Medical Officer of CytoSorbents commented, "We would like to thank the independent DSMB for the prompt review of the full unblinded dataset from the first 80 patients enrolled in the STAR-T trial. We are very pleased with the recommendation to continue the study as planned without modifications that now allows us to push towards the finish line in an expedited fashion. Based on the continued excitement and strong contributions from our U.S. and Canadian investigative sites, we continue to project that the trial, which remains blinded, will complete enrollment this summer."

07:03 EDT Applied UV engages Quantiva to integrate AI into PURONet, Airocide systems - Applied UV has engaged Quantiva, a provider of AI-driven consulting and software engineering services and solutions, to support the further development and expansion of the Company's proprietary indoor air quality monitoring software, PURONet. The initial objective of the collaboration is to leverage Machine Learning and Artificial Intelligence to expand the capabilities of Applied UV's flagship brand, Airocide, a patented air purification technology originally co-developed by the University of Wisconsin for use by NASA to grow crops in space. Applied UV Founder, CEO and Director Max Munn, stated, "We are excited about the opportunity to collaborate with Quantiva to advance the development of our proprietary PURONet indoor air monitoring software, particularly in the rapidly growing field of food preservation and food security. The impact of crop loss is felt all around the world, and we believe our proven Airocide brand can help mitigate this loss, improving societal outcomes globally. We look forward to our next-generation product launch which we anticipate being completed in late 2023."

07:02 EDT TuanChe appoints Simon Li as CFO - TuanChe appointed Simon Li as CFO, effective from June 15. Prior to joining the company, Simon Li served as a partner at Hongmenge Beijing Private Equity Management from June 2020 to May 2023, leading its financing and investment portfolio management business lines. Prior to that, Li was the general manager of the capital market department of Chang'An NIO New Energy Automotive Technology. Li, as one of the founding partners, served as a managing director and the head of fund risk control at Ether Capital from April 2014 to August 2019. Li was an investment manager at Digital China from April 2012 to March 2014, and an associate manager in the transactions and restructuring department of KPMG Advisory China from September 2009 to April 2012.

07:01 EDT Canadian Solar to establish solar PV module production facility in Mesquite, TX - Canadian Solar announced that it is establishing a solar PV module production facility in Mesquite, Texas. Canadian Solar is building a state-of-the-art solar photovoltaic module manufacturing plant with an annual output of 5 GW, equivalent to approximately 20,000 high-power modules per day. The new facility represents an investment of over $250M and will create approximately 1,500 skilled jobs once it is fully ramped up. Production is expected to begin around the end of 2023. This will be Canadian Solar's first United States manufacturing facility, following its successful track record of production in Canada, China, Brazil, Thailand and Vietnam. In 2021, Canadian Solar relocated Recurrent Energy, its 17-year-old U.S. subsidiary, to Austin, spearheading the rapid growth of renewable energy in the Lone Star State as a solar and battery storage project developer.

06:58 EDT Target increases quarterly dividend 1.9% to $1.10 per share - The board of directors of Target has declared a quarterly dividend of $1.10 per common share, a 1.9% increase from the prior quarterly dividend of $1.08. The dividend is payable September 10 to shareholders of record at the close of business August 16.

06:56 EDT Daqo New Energy Phase 5A polysilicon production facility reaches full capacity - Daqo New Energy announced that its new Phase 5A polysilicon 100,000 MT production facility in Baotou city, Inner Mongolia, has reached full production capacity. With the addition of Phase 5A, the company's total annual nameplate production capacity has expanded to 205,000 MT.

06:37 EDT Ault Inc. plans to sell St. Petersburg, FL, multifamily property - Ault Alliance intends to take advantage of the growing demand and market interest by selling its centrally located, multifamily property in St. Petersburg, Florida, previously acquired through its subsidiary, Ault Global Real Estate Equities, in 2021 for $15.5M. The company believes that the location of the property, between Mirror Lake and Tampa Bay, with pedestrian access to Tampa Bay, along with its proximity to retail, hospitality, and office experiences makes it an attractive prospect for investors.

06:35 EDT Cerevel Therapeutics names Paul Burgess Chief Business Development Officer - Cerevel Therapeutics appointed Paul Burgess as Chief Business Development and Strategic Operations Officer, effective June 20. Burgess's most recent role was COO and CLO of Translate Bio. At Translate Bio, he led business development, legal, program management, quality, technical operations and partner collaborations. He joined Translate Bio in 2015 and remained until 2021. Prior to Translate Bio, Burgess worked in a legal role at a number of companies including Scholar Rock, Civitas Therapeutics, BIND Therapeutics and Transform Pharmaceuticals

06:32 EDT Verve Therapeutics announces research collaboration with Eli Lilly - Verve Therapeutics (VERV) announced an exclusive research collaboration with Eli Lilly and Company (LLY) focused on advancing Verve's preclinical stage in vivo gene editing program targeting lipoprotein(a) (Lp(a)). Elevated Lp(a) is an established and genetically validated, independent risk factor for atherosclerotic cardiovascular disease, ischemic stroke, thrombosis, and aortic stenosis. Under the terms of the collaboration, Verve will advance the research and development of the Lp(a) program through the completion of Phase 1 clinical development. Lilly will be responsible for subsequent development, manufacturing, and commercialization of the Lp(a) program. Under the terms of the agreement, Verve will receive $60M consisting of an upfront payment and equity investment. Research program costs through Phase 1 clinical trials will be funded by Lilly. Verve is also eligible to receive up to $465M in research, development, and commercial milestones, as well as tiered royalties on global net sales. In addition, following the completion of Phase 1 clinical trials, Verve has the right to opt-in to co-fund and share margins globally on the Lp(a) program (in lieu of receipt of milestones and royalties). The closing of the transaction is subject to customary closing conditions, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act.

06:22 EDT Vodafone, CK Hutchison agree to merge UK businesses - Vodafone Group and CK Hutchison Group Telecom Holdings Limited, a wholly owned subsidiary of CK Hutchison Holdings Limited announced on Wednesday that they have entered into binding agreements in relation to a combination of their UK telecommunication businesses, respectively Vodafone UK and Three UK. Margherita Della Valle, Vodafone Group CEO, described the merger of Vodafone UK and Three UK as being "great for customers, great for the country and great for competition." The Transaction is expected to result in substantial efficiencies totaling to more than GBP 700 million of annual cost and capex synergies by the fifth full year post-completion, with an implied NPV of over GBP 7 billion, Vodafone said in a statement, adding that in addition to cost and capex efficiencies, there is also an opportunity to realize material revenue synergies underscored by greater access to the consumer market, cross-selling opportunities from the Vodafone UK and Three UK mobile bases, and incremental opportunities from accelerated Enterprise 5G use-cases. MergeCo expects to incur approximately GBP 500 million of integration costs, most of which will be incurred in the first five years post-completion. No cash consideration to be paid, with Vodafone UK and Three UK contributed with differential debt amounts at completion of the Transaction to achieve MergeCo ownership of 51:49. Vodafone UK will be contributed with GBP 4.3 billion and Three UK with GBP 1.7 billion, subject to customary completion adjustments. The initial total debt in MergeCo is expected to be approximately GBP 6.0 billion, of which the GBP 1.7 billion amount owing to CKHGT will be refinanced. MergeCo will be consolidated in Vodafone's financial statements and Vodafone has agreed to provide the initial debt financing to the joint venture. In connection with the Transaction, Morgan Stanley is acting as lead financial adviser to Vodafone, and Slaughter and May is acting as legal adviser to Vodafone. Robey Warshaw has also provided advice to Vodafone in connection with the Transaction. Reference Link

06:01 EDT Armada Hoffler authorizes $50M share repurchase program - Armada Hoffler has authorized the repurchase of an aggregate of $50M of the company's shares of common stock and Series A preferred stock in a newly established share repurchase program. The program may be suspended or discontinued at any time and does not obligate Armada Hoffler to make any purchases of its stock.

05:58 EDT Siemens to invest EUR 2B to boost future growth, innovation - In a press release, Siemens said, "To boost future growth, drive innovation and increase resilience, Siemens presented its investment strategy which includes EUR 2 billion mainly for new manufacturing capacity as well as innovation labs, education centers and other own sites. Siemens today announced a new high-tech factory in Singapore, to serve the booming Southeast Asia markets. New high-tech factory in Singapore. In addition, there is an expected increase of around EUR 0.5 billion in research and development, such as artificial intelligence and the industrial metaverse, in fiscal year 2023 versus prior year. This R&D is focused on strengthening Siemens' leading position in core technologies including simulation, digital twins, artificial intelligence or power electronics, as well as supporting the development of the Siemens Xcelerator open digital business platform. The company recently announced a partnership with Microsoft to speed up code generation for industry automation by using ChatGPT. With NVIDIA, Siemens is working to build the industrial metaverse to improve design, planning, production and operation of factories and infrastructures...To meet growing demand in Southeast Asia, Siemens today announced an entirely new high-tech factory in Singapore, which will be developed using Siemens' own leading digital twin and innovative, intelligent hardware technologies. Investment in the factory will be around EUR 200 million. The plant will set a new standard for connectivity to showcase the possibilities of digitalization, as well as incorporating highly-automated manufacturing processes. The investment will create over 400 jobs...As part of its investment strategy and fast-growing business in China, Siemens will also expand its digital factory in Chengdu to serve the local growth opportunities in China for China, investing EUR 140 million and creating 400 new jobs. Many of Siemens' Chinese customers are early adopters of new technologies especially in digitalization and high-tech manufacturing. This is why Siemens also announced the investment in a new digital R&D Innovation Center in Shenzhen to speed up development of motion control systems with digitalization and power electronics technology. The Siemens Xcelerator open digital business platform was launched in China in November 2022." Reference Link

05:18 EDT Addex Therapeutics increases share capital to create treasury shares - Addex Therapeutics announced that it has increased its share capital from CHF 1,153,483.11 to CHF 1,329,483.11 through the issue of 17,600,000 new registered shares at a nominal value of CHF 0.01 each to Addex Pharma S.A, its 100% wholly-owned subsidiary. The new shares, issued from the company's capital band, are listed on the SIX Swiss Exchange. The transaction has been executed to provide the Group with additional future financing flexibility. The total number of issued shares increased to 132,948,311 at a nominal value of CHF 0.01 each, whilst the number of outstanding shares remains unchanged.

05:07 EDT Mullen Automotive issues shareholder letter regarding decrease in share price - Mullen Automotive provided a business update letter to shareholders. "We want to respond to the many emails and calls regarding the decrease in our share price. Since March 31, 2023, our stock has declined 90% from $3.25 per share. On June 13, 2023, the Company's common stock closed at $0.32 per share. The Company currently trades at a discount to its current cash position of $135 million or $.038 per share. Despite the decline in stock price, management believes we are in position to meet the previously announced objectives for moving first into the production and then sale of our Class 3 commercial vehicles during the quarter ending Sept. 30, 2023. As per the Company's last reported financial position on March 31, 2023, we had $86.7 million of cash available to operations and $0.68 of cash value per share. Our book value per share was $2.08 on March 31, 2023. In addition to cash, the Company has completed two acquisitions that added valuable, unencumbered assets to the balance sheet: On Sept. 7, 2022, Bollinger Motors became a majority-owned EV truck company of Mullen Automotive, with a product portfolio that includes both the B1 and B2 electric SUV and pickup trucks and Class 4-6 commercial cab chassis trucks. Mullen's 60% acquisition stake of Bollinger for $148 million included $77 million to fund all vehicle development, manufacturing and capital needs to launch the class 4 EV chassis cab truck (Bollinger B4). Bollinger plans are still on track to launch customer pilots in the quarter ending Dec. 31, 2023, and the start of sales in the quarter ending June 30, 2024. On Dec. 1, 2022, Mullen purchased certain assets of Electric Last Mile Solutions ("ELMS") for $105 million, which included all of the IP and a 650,000-square-foot manufacturing plant in Mishawaka, Indiana. The acquisition also included work in progress on inventory of approximately 400 Class 1 electric van kits and batteries, which can be sold at an MSRP of $36,500 each. The ELMS assets purchased included all of the engineering development of commercial vehicle classes 1 and 3. The Company intends to manufacture the Mullen FIVE EV Crossover and Bollinger B1 and B2 SUVs and trucks at the Mishawaka Plant. In addition to acquisition assets listed above, Mullen's Tunica, Mississippi, assembly facility has over 120,000 square feet of manufacturing space on 100 acres of land. The Tunica facility is in the final stages of equipment installation for the launch of Mullen's commercial Class 3 production in the quarter ending Sept. 30, 2023. To date, the Company has filed over 200 U.S. and international patent applications, with 90 patents granted to date, related to vehicle design, technology, safety and convenience features in support of the Mullen FIVE consumer vehicle program. The Company has received $279 million in purchase orders from Randy Marion Automotive Group for Mullen Class 1 and Class 3 EV vans and trucks. Randy Marion, based in North Carolina, is one of the largest commercial vehicle dealer groups in the U.S."